
Although some expected an opposition due to CORONIL misleading the public as a cure for covid-19, the order is the result of another mark claiming priority.
ABOUT THE AUTHOR

Deepak Gogia
Deepak Gogia is a Partner with K&S Partners and has over 25 years of experience in patent litigation.